Dana-Farber Cancer Institute
Avatar

Continued Progress in MDS: Novel Therapies and Immune Checkpoint Inhibitors

By Dana-Farber Cancer Institute FEATURING Amer Zeidan
By Dana-Farber Cancer Institute FEATURING Amer Zeidan
208 views
February 14, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Related Videos

21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.6K views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

735 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

275 views
14:32

Summary of Recent Updates in MDS

Vanderbilt University Medical Center (VUMC)

S. Ball

444 views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views
23:04

Differentiation of CHIP, ICUS, CCUS, MDS, and VEXAS Syndrome

MyCancerHaven

R. Vij, S. Abedin

255 views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

757 views
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

915 views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

406 views
20:58

New

Defining Risk of Progression in CHIP/CCUS: A Pathologists' Perspecti…

16th International Congress on Myeloproliferative Neoplasms

R. Hasserjian

91 views
23:37

Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6

Rush University Medical Center

E. Bhaimia

343 views
18:44

Current and Emerging Treatment Approaches for Patients With AML or M…

University of Miami Sylvester Comprehensive Cancer Center

S. Venugopal

136 views
13:26

Chronic GvHD: Main Complications After ASCT

Steven Pavletic

368 views
09:42

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Pr…

2024 ASCO® Annual Meeting Insights Hub

M. Al Malki

274 views
25:38

Allo-HSCT Conditioning Regimens: Current Status and Future Directions

Rush University Medical Center

C. Brunstein

266 views
25:12

Bone Marrow Failure: The Importance of Mutational Testing

Rush University Medical Center

J. Shammo

261 views
16:55

Making Sense of the New Classification Systems for MDS in 2024

Moffitt Cancer Center

R. Komrokji

444 views
12:15

Using Transplant in Patients With p53 Mutant MDS or AML

Moffitt Cancer Center

H. Elmariah

330 views
17:01

Are We Closer to Conquering HR-MDS?

SOHO Brazil 2024

R. Komrokji

104 views
28:33

The Truth About Current Consensus Statements on Hematopoietic Cell T…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. Gale

531 views
AUTOPLAY